3 results
8-K
EX-99.1
AXLA
Axcella Health Inc.
23 Mar 20
Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:03pm
.
“Meanwhile, the impacts of the COVID-19 outbreak on our society and in the medical community are far-reaching and rapidly evolving,” continued Mr … Program
Presented mechanistic data on the company’s hematology product candidate AXA4010 at the 61st American Society of Hematology (ASH) Annual
8-K
AXLA
Axcella Health Inc.
12 Nov 19
Results of Operations and Financial Condition
4:04pm
American Society of Hematology (ASH) Annual Meeting and Exposition
Initiated a non-IND clinical study to assess the impact of AXA4010 on safety
- Prev
- 1
- Next